NYSE$UHT

Universal Health Realty Income Trust · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Reported first quarter financial results, with net income increasing due to property income and reduced expenses, offset by higher interest expenses.

Universal Health Realty Income Trust reported a net income of $5.3 million, or $0.38 per diluted share, for the first quarter of 2024, compared to $4.5 million, or $0.32 per diluted share, for the same period in 2023. FFO increased to $12.4 million, or $0.90 per diluted share, from $11.4 million, or $0.82 per diluted share in the prior year.

  • Net income increased by $841,000, or $0.06 per diluted share, compared to Q1 2023.
  • Funds from operations (FFO) rose to $12.4 million, or $0.90 per diluted share.
  • Increase in net income was due to higher property income and reduced expenses related to vacant facilities, offset by increased interest expense.
  • A dividend of $0.725 per share was declared on March 6, 2024, and paid on March 29, 2024.

Headline financials

Total Revenue

$25.1M

Previous: $23.2M+8.2%
EPS

$0.38

Previous: $0.32+18.8%
Dividend Paid Per Share

$0.72

Previous: $0.71+1.4%
Funds From Operations

$12.4M

Previous: $11.4M+8.9%
FFO Per Diluted Share

$0.90

No prior period
Free Cash Flow

$5.3M

Previous: -$9.15M+157.9%
Net Income

$5.3M

Previous: $4.46M+18.9%
Operating Income

$9.46M

Previous: $7.79M+21.6%
Gross Profit

$25.1M

Previous: $23.2M+8.2%
Stock-Based Comp

$202K

Previous: $188K+7.4%

Revenue & EPS history

UHT · Revenue · Quarterly

$25.1M

Q1 2024+8.2%vs Q1 2023

Revenue by segment

UHT · $658K total across 2 segments · Q3 2023

  • Other Revenue - Non-related parties
    $404K+82.8%
  • Other Revenue - UHS Facilities
    $254K-0.4%

Forward guidance

Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially.

Headwinds

  • Decreases in staffing availability and related increases to wage expense
  • Impact of government and administrative regulation of the health care industry
  • Declining patient volumes and unfavorable changes in payer mix
  • Potential disruptions related to supplies required for our tenants’ employees and patients
  • Potential increases to other expenditures.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

-0.0%

Avg return

Earnings day

-0.2%

Avg return

5 days after

+1.0%

Avg return

30 days after

52%

34 / 65 earnings

Positive

+12.7%

Q1 2020

Best reaction

-6.8%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.9%-0.8%
Q4 2025+0.2%-0.7%-9.7%
Q3 2025+2.1%+4.9%+12.7%
Q1 2025-0.5%+1.7%+2.2%
Q4 2024+0.8%+1.9%+3.0%
Q3 2024-2.9%-4.6%-2.2%
Q2 2024+2.5%+1.6%+5.1%
Q1 2024+0.8%+5.8%+10.1%
Q4 2023+0.2%-4.1%-9.7%
Q3 2023+1.1%-0.9%+3.4%
Q2 2023-3.4%-3.7%-5.2%
Q1 2023-5.9%-6.5%-8.3%
Q4 2022-1.5%-5.8%-11.9%
Q3 2022+5.3%+8.8%+15.6%
Q2 2022+2.3%+2.8%-0.1%
Q1 2022-3.1%-11.1%-7.3%
Q4 2021+1.2%+4.2%+3.4%
Q3 2021+0.5%-0.6%+2.2%
Q2 2021-0.7%-1.8%-3.7%
Q1 2021+0.2%-3.0%-0.0%
Q4 2020-6.1%-6.3%+7.8%
Q3 2020-2.3%+2.7%+14.5%
Q2 2020+0.7%+3.2%-0.1%
Q1 2020+12.7%+9.9%+5.9%
Q4 2019-6.6%-8.1%-21.6%
Q3 2019+3.7%+8.4%+0.7%
Q2 2019+1.6%+3.2%+5.6%
Q1 2019+3.8%+3.7%+8.0%
Q4 2018+0.3%+0.2%+1.1%
Q3 2018-6.8%-11.2%-6.2%
Q2 2018+0.8%+4.4%+15.6%
Q1 2018+4.1%+2.0%+3.1%
Q4 2017+3.0%+6.4%+8.6%
Q3 2017-0.8%-2.9%-0.2%
Q2 2017-5.6%-6.7%-10.0%
Q1 2017+0.3%+0.9%+3.0%
Q4 2016-0.1%-1.3%+0.5%
Q3 2016-4.1%-5.8%-0.3%
Q2 2016-1.1%+0.7%+3.5%
Q1 2016-1.5%
Q4 2015+0.6%
Q3 2015-0.1%
Q2 2015+0.7%
Q1 2015-2.3%
Q4 2014-0.7%
Q3 2014+1.4%
Q2 2014-1.1%
Q1 2014-0.2%
Q4 2013+1.6%
Q3 2013+1.9%
Q2 2013-0.5%
Q1 2013-1.9%
Q1 2011-0.2%
Q4 2012+1.7%
Q3 2012-1.7%
Q4 2011-1.0%
Q2 2012-1.0%
Q1 2012+0.6%
Q4 2009-1.2%
Q3 2010+0.0%
Q3 2011+0.0%
Q2 2011+0.3%
Q4 2010+0.3%
Q2 2010+0.3%
Q1 2010+4.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro